Indonesia's Bio Farma secures UNICEF contract for oral polio vaccine type 2

Indonesia's PT Bio Farma (Persero), the holding company for pharmaceutical state-owned enterprises (SOEs), will export i...

October 4, 2022 | Tuesday | News
Australia leads research to develop next generation of TB vaccines

The University of Sydney and The Centenary Institute, together with collaborators have been awarded an AU$19 million con...

September 30, 2022 | Friday | News
Australia invests in new study on COVID-19 vaccines with future variants emerging

The Australian government is investing in a new study on COVID-19 vaccines and infection to ultimately improve the care ...

September 26, 2022 | Monday | News
Singapore grants interim authorisation for first bivalent COVID-19 booster vaccine

Singapore Health Sciences Authority (HSA) has granted an interim authorisation for the use of Moderna’s Omicr...

September 14, 2022 | Wednesday | News
Australia explores use of vaccinia virus-based vaccines to fight monkeypox

New research suggests recommended vaccinia virus (VACV)-based vaccines will mount a robust immune response against the m...

September 13, 2022 | Tuesday | News
China approves inhaled vaccine as COVID-19 booster dose

CanSino Biologics Inc has announced that the National Medical Products Administration of China (NMPA) has granted the co...

September 12, 2022 | Monday | News
Indonesian firm Bio Farma set to launch IndoVac COVID-19 vaccine

PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, has nnounced a new milestone in...

September 12, 2022 | Monday | News
Polyplus Builds on Research and Commercial mRNA Support Portfolio with in vivo-jetRNA®+ Transfection Reagent

The new in vivo-jetRNA®+ transfection reagent an efficient, stable, and safe delivery system leading to 100% mR...

September 8, 2022 | Thursday | News
Bharat Biotech's COVID-19 intranasal vaccine gets 'emergency use' approval in India

Indian firm Bharat Biotech has announced that iNCOVACC (BBV154) has received approval under Restricted Use in Emergency ...

September 7, 2022 | Wednesday | News
China's Sinovac makes progress with trivalent COVID-19 vaccine

China-based Sinovac Biotech has announced that the Chilean Public Health Institute (Instituto de Salud Pública, I...

September 7, 2022 | Wednesday | News
Indonesia approves Takeda's dengue vaccine

Japanese firm Takeda has announced that the company’s dengue vaccine, QDENGA (Dengue Tetravalent Vaccine [Live, At...

August 23, 2022 | Tuesday | News
Moderna to build first mRNA production facility in Southern Hemisphere

Australia's Monash University has announced that US-based firm Moderna will be joining other world-leading research and ...

August 16, 2022 | Tuesday | News
CSIRO opens 'missing link' lab to developing Australian vaccine pipeline

Commonwealth Scientific and Industrial Research Organisation (CSIRO), an Australian Government agency responsible for sc...

August 11, 2022 | Thursday | News
UK advances key tools for Monkeypox vaccine research

The Coalition for Epidemic Preparedness Innovations (CEPI), Norway has announced funding of up to $375,000 to the UK Med...

August 1, 2022 | Monday | News
Keeping Pace with Mutating Viruses

As of July 2022, uncertainty persists as waves of SARS-CoV-2 continue to emerge. Over time, new virus variants arise and...

July 30, 2022 | Saturday | Opinion
World-class Foot and Mouth Disease vaccine site to come up in South Korea

Argentina-based Biogénesis Bagó, an international biotechnology company focused on animal health and globa...

July 26, 2022 | Tuesday | News
Korea's IVI inks MoU with Moderna for vaccine R&D

South Korea-based International Vaccine Institute (IVI) and US-based Moderna have signed a Memorandum of Understanding (...

July 21, 2022 | Thursday | News
SK bioscience to manufacture Novavax' COVID-19 vaccine against omicron

South Korea's SK bioscience has extended its partnership with Novavax, a US-based biotechnology company specializing in ...

July 22, 2022 | Friday | News